The school will use UW Health as a trial site to test an “antibody cocktail” developed by Regeneron Pharmaceuticals, a company based in New York. Researchers are calling the treatment “REGN-COV2.”
University Communications
The school will use UW Health as a trial site to test an “antibody cocktail” developed by Regeneron Pharmaceuticals, a company based in New York. Researchers are calling the treatment “REGN-COV2.”